Free Trial
OTCMKTS:MYMX

Mymetics (MYMX) Stock Price, News & Analysis

$0.0003 0.00 (0.00%)
As of 06/27/2025

About Mymetics Stock (OTCMKTS:MYMX)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0003
$0.0010
Volume
N/A
Average Volume
N/A
Market Capitalization
$45.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

Receive MYMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mymetics and its competitors with MarketBeat's FREE daily newsletter.

MYMX Stock News Headlines

Sp Bmv Ipc Esg Tilted Heavy (MYMX)
PLTXF PlantX Life Inc.
A grave, grave error.
President Donald Trump made headlines last month with a staggering claim. He stated that since taking office, more than $12 trillion in private investments into America have been “practically committed” on his watch. "Nobody's ever seen numbers like we have," he said, crediting his agenda of tariffs, tax cuts, and deregulation with making the difference. If true, the figure would indeed be astonishing – potentially tripling the roughly $4 trillion in gross private investment the US reported all of last year.
Mymetics Stock (OTC:MYMX), Short Interest Report
Mymetics Corporation (MYMX)
See More Headlines

MYMX Stock Analysis - Frequently Asked Questions

Mymetics' stock was trading at $0.0010 at the beginning of 2025. Since then, MYMX stock has decreased by 70.0% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mymetics investors own include Dynavax Technologies (DVAX), Fujitsu (FJTSY), Genocea Biosciences (GNCA), Maxar Technologies (MAXR), Revance Therapeutics (RVNC), Axcelis Technologies (ACLS) and Allied Gaming & Entertainment (AGAE).

Company Calendar

Today
7/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MYMX
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.08 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
144,000
Optionable
Not Optionable
Beta
2.37
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTCMKTS:MYMX) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners